Last quarter (Q4 2022), Laboratorios Farmaceuticos Rovi's total revenue was €242.20M, an increase of 30.80% from the same quarter last year. In Q4, Laboratorios Farmaceuticos Rovi's net income was €78.17M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	€ 817.70M	€ 817.70M	€ 648.68M	€ 419.96M	€ 381.31M	€ 303.20M
Cost of Revenue	€ 298.08M	€ 298.08M	€ 263.86M	€ 178.65M	€ 166.61M	€ 128.61M
Gross Profit	€ 519.61M	€ 519.61M	€ 384.82M	€ 241.31M	€ 214.71M	€ 174.59M
Operating Expense	€ 263.76M	€ 263.76M	€ 203.34M	€ 163.88M	€ 171.52M	€ 157.13M
Operating Income	€ 255.85M	€ 255.85M	€ 181.49M	€ 77.43M	€ 43.18M	€ 17.46M
Net Non Operating Interest Income Expense	€ 921.00K	€ 921.00K	€ -837.00K	€ -1.07M	€ -876.00K	€ -696.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	€ 257.97M	€ 257.97M	€ 182.63M	€ 72.58M	€ 41.88M	€ 16.68M
Tax Provision	€ 58.30M	€ 58.30M	€ 29.55M	€ 11.52M	€ 2.61M	€ -1.22M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	€ 199.67M	€ 199.67M	€ 153.08M	€ 61.06M	€ 39.27M	€ 17.89M
Basic EPS	€ 3.79	€ 3.73	€ 2.76	€ 1.10	€ 0.71	€ 0.35
Diluted EPS	€ 3.79	€ 3.73	€ 2.76	€ 1.10	€ 0.71	€ 0.35
Basic Average Shares	€ 210.98M	€ 53.47M	€ 55.40M	€ 55.39M	€ 55.18M	€ 51.22M
Diluted Average Shares	€ 210.98M	€ 53.47M	€ 55.40M	€ 55.39M	€ 55.18M	€ 51.22M
Dividend Per Share	€ 0.96	€ 0.96	€ 0.38	€ 0.18	€ 0.08	€ 0.00
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	€ 3.47M	€ 839.00K	€ 327.00K	€ 179.00K	€ 3.56M
Total Expenses	€ 561.85M	€ 561.85M	€ 467.19M	€ 342.53M	€ 338.13M	€ 285.75M
Net Income From Continuing And Discontinued Operation	€ 199.67M	€ 199.67M	€ 153.08M	€ 61.06M	€ 39.27M	€ 17.89M
Normalized Income	€ 198.28M	€ 198.27M	€ 151.42M	€ 64.24M	€ 39.44M	€ 17.91M
Interest Expense	€ 606.00K	€ 606.00K	€ 669.00K	€ 806.00K	€ 648.00K	€ 712.00K
EBIT	€ 258.57M	€ 258.57M	€ 183.30M	€ 73.39M	€ 42.53M	€ 17.39M
EBITDA	€ 281.44M	€ 281.44M	€ 204.66M	€ 92.98M	€ 60.74M	€ 29.44M

Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing